BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30544424)

  • 1. Dark chocolate modulates platelet function with a mechanism mediated by flavan-3-ol metabolites.
    Montagnana M; Danese E; Angelino D; Mena P; Rosi A; Benati M; Gelati M; Salvagno GL; Favaloro EJ; Del Rio D; Lippi G
    Medicine (Baltimore); 2018 Dec; 97(49):e13432. PubMed ID: 30544424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavan-3-ol-enriched dark chocolate and white chocolate improve acute measures of platelet function in a gender-specific way--a randomized-controlled human intervention trial.
    Ostertag LM; Kroon PA; Wood S; Horgan GW; Cienfuegos-Jovellanos E; Saha S; Duthie GG; de Roos B
    Mol Nutr Food Res; 2013 Feb; 57(2):191-202. PubMed ID: 23136121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans.
    Mullen W; Borges G; Donovan JL; Edwards CA; Serafini M; Lean ME; Crozier A
    Am J Clin Nutr; 2009 Jun; 89(6):1784-91. PubMed ID: 19403635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavan-3-ol-methylxanthine interactions: Modulation of flavan-3-ol bioavailability in volunteers with a functional colon and an ileostomy.
    Ottaviani JI; Fong RY; Borges G; Kimball J; Ensunsa JL; Medici V; Pourshahidi LK; Kane E; Ward K; Durkan R; Dobani S; Lawther R; O'Connor G; Gill CIR; Schroeter H; Crozier A
    Free Radic Biol Med; 2023 Feb; 196():1-8. PubMed ID: 36621554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of commercially available chocolate- and cocoa-containing products in the United States. 2. Comparison of flavan-3-ol content with nonfat cocoa solids, total polyphenols, and percent cacao.
    Miller KB; Hurst WJ; Flannigan N; Ou B; Lee CY; Smith N; Stuart DA
    J Agric Food Chem; 2009 Oct; 57(19):9169-80. PubMed ID: 19754118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Urinary Phenyl-γ-Valerolactones as Biomarkers of Dietary Flavan-3-ol Exposure.
    Parmenter BH; Shinde S; Croft K; Murray K; Bondonno CP; Genoni A; Christophersen CT; Bindon K; Kay C; Mena P; Del Rio D; Hodgson JM; Bondonno NP
    J Nutr; 2023 Aug; 153(8):2193-2204. PubMed ID: 37394116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Urinary Phenyl-γ-Valerolactones and Related Valeric Acids in Human Urine on Consumption of Apples.
    Anesi A; Mena P; Bub A; Ulaszewska M; Del Rio D; Kulling SE; Mattivi F
    Metabolites; 2019 Oct; 9(11):. PubMed ID: 31671768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic profile and urinary excretion of phenyl-γ-valerolactones upon consumption of cranberry: a dose-response relationship.
    Favari C; Mena P; Curti C; Istas G; Heiss C; Del Rio D; Rodriguez-Mateos A
    Food Funct; 2020 May; 11(5):3975-3985. PubMed ID: 32396592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Plasma Appearance of (+)-Catechin and (-)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa-A Randomized, Double-Blind Trial.
    Ellinger S; Reusch A; Henckes L; Ritter C; Zimmermann BF; Ellinger J; Galensa R; Stehle P; Helfrich HP
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does epicatechin contribute to the acute vascular function effects of dark chocolate? A randomized, crossover study.
    Dower JI; Geleijnse JM; Kroon PA; Philo M; Mensink M; Kromhout D; Hollman PC
    Mol Nutr Food Res; 2016 Nov; 60(11):2379-2386. PubMed ID: 27329037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
    Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
    Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the bioavailability of flavan-3-ols in humans: A systematic review and comprehensive data analysis.
    Di Pede G; Mena P; Bresciani L; Achour M; Lamuela-Raventós RM; Estruch R; Landberg R; Kulling SE; Wishart D; Rodriguez-Mateos A; Crozier A; Manach C; Del Rio D
    Mol Aspects Med; 2023 Feb; 89():101146. PubMed ID: 36207170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Consumption of Flavan-3-ol-Enriched Dark Chocolate Affects Human Endogenous Metabolism.
    Ostertag LM; Philo M; Colquhoun IJ; Tapp HS; Saha S; Duthie GG; Kemsley EK; de Roos B; Kroon PA; Le Gall G
    J Proteome Res; 2017 Jul; 16(7):2516-2526. PubMed ID: 28585834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic and analytical strategies for the quantification of phenyl-γ-valerolactone conjugated metabolites in human urine.
    Brindani N; Mena P; Calani L; Benzie I; Choi SW; Brighenti F; Zanardi F; Curti C; Del Rio D
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28440064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of dietary flavan-3-ol intakes with plasma phenyl-γ-valerolactones: analysis from the TUDA cohort of healthy older adults.
    Angelino D; Caffrey A; McNulty H; Gill CI; Mena P; Rosi A; Moore K; Hoey L; Clements M; Laird E; Boyd K; Mullen B; Pucci B; Jarrett H; Cunningham C; Ward M; Strain JJ; McCarroll K; Moore AJ; Molloy AM; Del Rio D
    Am J Clin Nutr; 2023 Aug; 118(2):476-484. PubMed ID: 37307990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy.
    Auger C; Mullen W; Hara Y; Crozier A
    J Nutr; 2008 Aug; 138(8):1535S-1542S. PubMed ID: 18641203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy.
    Stalmach A; Mullen W; Steiling H; Williamson G; Lean ME; Crozier A
    Mol Nutr Food Res; 2010 Mar; 54(3):323-34. PubMed ID: 19937856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague-Dawley rats.
    Neilson AP; Sapper TN; Janle EM; Rudolph R; Matusheski NV; Ferruzzi MG
    J Agric Food Chem; 2010 Jun; 58(11):6685-91. PubMed ID: 20446738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans.
    Stalmach A; Troufflard S; Serafini M; Crozier A
    Mol Nutr Food Res; 2009 May; 53 Suppl 1():S44-53. PubMed ID: 18979506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols.
    Clifford MN; van der Hooft JJ; Crozier A
    Am J Clin Nutr; 2013 Dec; 98(6 Suppl):1619S-1630S. PubMed ID: 24172307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.